HEMOTAG® Assessment for Short-term Outcomes of Heart Failure

Clinical trial NCT04149743 · RECRUITING

Trial details

NCT number: NCT04149743
Sponsor: Aventusoft, LLC.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Heart Failure (HF)

Start date: 2022-01-31
Primary completion: 2024-12-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.